Followers | 375 |
Posts | 16968 |
Boards Moderated | 4 |
Alias Born | 03/07/2014 |
![](https://investorshub.advfn.com/uicon/458287.png?cb=1657037051)
Wednesday, April 02, 2014 11:19:25 AM
According to the FDA and the Hippocratic Oath among other sources, I don't believe DEATH of the patient or serious complications worse than the state of the patient prior to being given "said treatment" is considered "treating" anything, IMHO. Further, there is only "research" going on, in this field as of this date, I am not aware of any approved "treatments" in existence? A "treatment" is generally an FDA or similar regulatory body, peer reviewed and widely accepted method/drug/device within the medical community. I don't know of anything in "cardiac stem cells" that meets that criteria yet?
According to the U.S. FDA, there is only one, FDA "stem cell" approved "anything" in existence to date. In fact, the FDA made a point to create a "warning" to this effect for consumers:
http://www.fda.gov/forconsumers/consumerupdates/ucm286155.htm
"FDA has approved only one stem cell product, Hemacord, a cord blood-derived product manufactured by the New York Blood Center and used for specified indications in patients with disorders affecting the body’s blood-forming system."
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM